Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Longeveron Inc
(NQ:
LGVN
)
1.750
+0.080 (+4.79%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Longeveron Inc
< Previous
1
2
3
Next >
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate in Upcoming Planet MicroCap Showcase
April 26, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Closes on Multimillion-Dollar Warrant Exercise Offering, Public Offering
April 19, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for ~$6.2M
April 17, 2024
Via
Investor Brand Network
New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging People
April 17, 2024
Via
Investor Brand Network
Five Significant Strides Made in Alzheimer’s Research in 2023
January 05, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Closes on Public Offering Valued at Estimated $5.2M
April 12, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Releases Pricing for Mulitmillion-Dollar Public Offering
April 09, 2024
Via
Investor Brand Network
Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update
March 28, 2024
Via
Investor Brand Network
Researchers Link Type 2 Diabetes to Heightened Alzheimer’s Risk
March 27, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Board Approves 1-for-10 Reverse Stock Split
March 20, 2024
Via
Investor Brand Network
Study Links Parkinson’s Onset in Rocky Mountain Area to Agricultural Pesticides
March 01, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Reports on Year-End 2023 Financial Results, Corporate Update
February 28, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Announces Plans to Release Year-End 2023 Financial Results, Corporate Update
February 22, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc.’s (NASDAQ: LGVN) ELPIS Trial Demonstrates Potential Survival Benefit of Lomecel-B(TM) for HLHS Patients
February 21, 2024
Via
Investor Brand Network
Study Links Ramadan Fasting to Lower Risk of Chronic Disease Development
February 14, 2024
Via
Investor Brand Network
Longeveron Inc.’s (NASDAQ: LGVN) Long-Term Follow-Up Data from Its ELPIS I Clinical Trial Presented at the 2023 Annual Scientific Sessions of the American Heart Association
February 07, 2024
Via
Investor Brand Network
BioMedNewsBreaks – H.C. Wainwright & Co. Reiterates ‘Buy’ Rating, $6 PT on Longeveron (NASDAQ: LGVN)
February 06, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Dietician Tips for Boosting Muscle Mass, Living Longer
January 31, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Granted US Patent Allowance for Key Technology Behind Lead Investigation Product
January 29, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Scientists Discover Alzheimer’s Can Be Categorized into Five Subtypes
January 18, 2024
Via
Investor Brand Network
Studies Suggest Fasting Could Tone Down Alzheimer’s Signs
December 22, 2023
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Enters Definitive Agreement for $2.36M Registered Direct Offering
December 21, 2023
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Reports Additional Positive Clinical Data, Imaging Biomarker Results in Phase 2a Lomecel-B(TM) Trial
December 20, 2023
Via
Investor Brand Network
Smart Trackers Could Detect Aging-Related Complications in Seniors
December 12, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Eyes ‘Encouraging’ Results from CLEAR MIND Trial
December 01, 2023
Via
Investor Brand Network
Hidden Belly Fat Could Be a Precursor of Alzheimer’s Onset Years Later
November 30, 2023
Via
Investor Brand Network
Longeveron Inc. (NASDAQ: LGVN) Encouraged by Positive Results from Phase 2a Trial in Patients with Mild AD; Explores Paths Forward for the Development of Lomecel-B(TM)
November 21, 2023
Via
Investor Brand Network
Study Links Cat Parasite to Accelerated Frailty in Aging People
November 16, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Featured in Bell2Bell Podcast
November 14, 2023
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Study Survival Data Reported at AHA’s 2023 Scientific Sessions
November 13, 2023
Via
Investor Brand Network
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.